INMED PHARMACEUTICALS (Germany) Performance
| MWG0 Stock | 3.94 0.20 4.83% |
On a scale of 0 to 100, INMED PHARMACEUTICALS holds a performance score of 4. The company retains a Market Volatility (i.e., Beta) of -2.13, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning INMED PHARMACEUTICALS are expected to decrease by larger amounts. On the other hand, during market turmoil, INMED PHARMACEUTICALS is expected to outperform it. Please check INMED PHARMACEUTICALS's sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether INMED PHARMACEUTICALS's current trending patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in INMED PHARMACEUTICALS INC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, INMED PHARMACEUTICALS reported solid returns over the last few months and may actually be approaching a breakup point. ...more
INMED |
INMED PHARMACEUTICALS Relative Risk vs. Return Landscape
If you would invest 362.00 in INMED PHARMACEUTICALS INC on September 26, 2024 and sell it today you would earn a total of 32.00 from holding INMED PHARMACEUTICALS INC or generate 8.84% return on investment over 90 days. INMED PHARMACEUTICALS INC is generating 0.5746% of daily returns assuming 10.0251% volatility of returns over the 90 days investment horizon. Simply put, 89% of all stocks have less volatile historical return distribution than INMED PHARMACEUTICALS, and 89% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
INMED PHARMACEUTICALS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for INMED PHARMACEUTICALS's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as INMED PHARMACEUTICALS INC, and traders can use it to determine the average amount a INMED PHARMACEUTICALS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0573
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MWG0 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.03 actual daily | 89 89% of assets are less volatile |
Expected Return
| 0.57 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average INMED PHARMACEUTICALS is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of INMED PHARMACEUTICALS by adding it to a well-diversified portfolio.
About INMED PHARMACEUTICALS Performance
By analyzing INMED PHARMACEUTICALS's fundamental ratios, stakeholders can gain valuable insights into INMED PHARMACEUTICALS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if INMED PHARMACEUTICALS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if INMED PHARMACEUTICALS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about INMED PHARMACEUTICALS INC performance evaluation
Checking the ongoing alerts about INMED PHARMACEUTICALS for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for INMED PHARMACEUTICALS INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| INMED PHARMACEUTICALS is way too risky over 90 days horizon | |
| INMED PHARMACEUTICALS appears to be risky and price may revert if volatility continues |
- Analyzing INMED PHARMACEUTICALS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether INMED PHARMACEUTICALS's stock is overvalued or undervalued compared to its peers.
- Examining INMED PHARMACEUTICALS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating INMED PHARMACEUTICALS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of INMED PHARMACEUTICALS's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of INMED PHARMACEUTICALS's stock. These opinions can provide insight into INMED PHARMACEUTICALS's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for INMED Stock analysis
When running INMED PHARMACEUTICALS's price analysis, check to measure INMED PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INMED PHARMACEUTICALS is operating at the current time. Most of INMED PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of INMED PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INMED PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of INMED PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |